GE Healthcare Technologies Inc
GEHC69.850USD
-1.470-2.06%
Handelsschluss 08/01, 16:00（ET）Kurse um 15 Minuten verzögert
31.89BMarktkapitalisierung
14.61KGV TTM
mehr Informationen über GE Healthcare Technologies Inc Unternehmen
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Unternehmensinformationen
BörsenkürzelGEHC
Name des UnternehmensGE Healthcare Technologies Inc
IPO-datumDec 15, 2022
Gegründet am2022
CEOMr. Kevin Michael O'Neill
Anzahl der mitarbeiter53000
WertpapierartOrdinary Share
GeschäftsjahresendeDec 15
Addresse500 West Monroe Street
StadtCHICAGO
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl60661
Telefon18337351139
Websitehttps://www.gehealthcare.com
BörsenkürzelGEHC
IPO-datumDec 15, 2022
Gegründet am2022
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1930.31%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
+55.32%
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
10.16K
+43.77%
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
9.12K
+51.33%
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1930.31%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Total Imaging
2.14B
44.80%
Total Ultrasound
1.24B
25.94%
Total PCS
753.00M
15.76%
Total PDx
632.00M
13.23%
Other
13.00M
0.27%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Total Imaging
2.14B
44.80%
Total Ultrasound
1.24B
25.94%
Total PCS
753.00M
15.76%
Total PDx
632.00M
13.23%
Other
13.00M
0.27%
Aktionärsstatistik
Aktualisiert: Fri, May 16
Aktualisiert: Fri, May 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.22%
BlackRock Institutional Trust Company, N.A.
5.53%
Capital Research Global Investors
4.81%
State Street Global Advisors (US)
4.22%
Dodge & Cox
3.63%
Other
70.58%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.22%
BlackRock Institutional Trust Company, N.A.
5.53%
Capital Research Global Investors
4.81%
State Street Global Advisors (US)
4.22%
Dodge & Cox
3.63%
Other
70.58%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
42.97%
Investment Advisor/Hedge Fund
24.76%
Hedge Fund
4.47%
Pension Fund
2.42%
Research Firm
2.34%
Sovereign Wealth Fund
1.42%
Bank and Trust
1.36%
Insurance Company
0.39%
Individual Investor
0.28%
Other
19.60%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
2397
368.46M
80.47%
-57.45M
2025Q1
2446
400.73M
87.52%
-35.60M
2024Q4
2344
405.16M
88.60%
-9.34M
2024Q3
2188
396.50M
86.79%
-11.03M
2024Q2
2081
391.61M
85.76%
-10.20M
2024Q1
2000
385.11M
84.39%
-2.29M
2023Q4
1855
385.99M
84.77%
-4.81M
2023Q3
1708
381.18M
83.73%
+1.51M
2023Q2
1574
374.50M
82.34%
-3.85M
2023Q1
1358
378.91M
83.35%
+182.70M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
51.21M
11.18%
-1.14M
-2.18%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
25.26M
5.52%
+396.70K
+1.60%
Mar 31, 2025
Capital Research Global Investors
21.96M
4.8%
-29.23M
-57.10%
May 30, 2025
State Street Global Advisors (US)
19.29M
4.21%
+390.65K
+2.07%
Mar 31, 2025
Dodge & Cox
16.59M
3.62%
-90.00K
-0.54%
Mar 31, 2025
Geode Capital Management, L.L.C.
11.71M
2.56%
+392.53K
+3.47%
Mar 31, 2025
Invesco Capital Management (QQQ Trust)
9.46M
2.07%
-24.14K
-0.25%
Jun 30, 2025
Citadel Advisors LLC
6.92M
1.51%
+6.43M
+1316.23%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
6.25M
1.36%
+1.84M
+41.76%
Dec 31, 2024
AllianceBernstein L.P.
5.96M
1.3%
-168.96K
-2.76%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: 11 hours ago
Aktualisiert: 11 hours ago
Name
Anteil
Invesco S&P Spin-Off ETF
7.32%
Langar Global HealthTech ETF
6.1%
Global X HealthTech ETF
3.96%
iShares U.S. Medical Devices ETF
3.85%
Absolute Select Value ETF
3.16%
VanEck Morningstar ESG Moat ETF
2.54%
VanEck Morningstar Wide Moat Value ETF
2.54%
Knowledge Leaders Developed World ETF
2.34%
VanEck Morningstar Wide Moat ETF
2.3%
First Trust Indxx Medical Devices ETF
2.16%
Mehr Anzeigen
Invesco S&P Spin-Off ETF
Anteil7.32%
Langar Global HealthTech ETF
Anteil6.1%
Global X HealthTech ETF
Anteil3.96%
iShares U.S. Medical Devices ETF
Anteil3.85%
Absolute Select Value ETF
Anteil3.16%
VanEck Morningstar ESG Moat ETF
Anteil2.54%
VanEck Morningstar Wide Moat Value ETF
Anteil2.54%
Knowledge Leaders Developed World ETF
Anteil2.34%
VanEck Morningstar Wide Moat ETF
Anteil2.3%
First Trust Indxx Medical Devices ETF
Anteil2.16%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
96.00M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
Apr 25, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023
May 23, 2023
Jun 15, 2023
May 22, 2023
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
